Skip to content
HowShorted

Compass Therapeutics, Inc. short interest in 2026

In 2026, Compass Therapeutics, Inc.'s disclosed short interest ran from 12.93% of shares outstanding on 15 Jan 2026 to 23.13% on 15 Sep 2026, a change of +10.20 percentage points. The year's high was 23.13% on 15 Sep 2026 and its low 12.33% on 30 Jan 2026, averaging 17.46% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.62 days on 31 Jul 2026. Full history: Compass Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Compass Therapeutics, Inc. in 2026

2026 in figures

Start of year
12.93% (15 Jan 2026)
End of year
23.13% (15 Sep 2026)
Change
+10.20 pp
High
23.13% (15 Sep 2026)
Low
12.33% (30 Jan 2026)
Average
17.46%
Highest days to cover
17.62 (31 Jul 2026)
SEC filings marked
7

Every report in 2026

Compass Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202612.93%7.80results (8-K)
30 Jan 202612.33%9.88
13 Feb 202612.57%11.30
27 Feb 202612.94%12.27
13 Mar 202613.39%11.8210-K filed, results (8-K)
31 Mar 202614.69%12.05
15 Apr 202614.66%9.43
30 Apr 202616.89%1.35
15 May 202617.23%4.0710-Q filed, results (8-K)
29 May 202618.47%6.41
15 Jun 202618.05%9.48
30 Jun 202620.62%8.89
15 Jul 202621.82%15.67
31 Jul 202622.14%17.62
14 Aug 202622.32%9.7810-Q filed, results (8-K)
31 Aug 202622.65%17.26
15 Sep 202623.13%15.99

See also: Compass Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.